RE: Might be more interest in GDR24 Jan 2022 10:42
Thanks for the reply Inphobe.
What's the assessment of holders re. this company? It seems to have top-class tech, yet been a bit unlucky re. achieving big commercial sales up to now. The ability to identify a gene that makes a baby susceptible to deafness from an anti-biotic was once the stuff of science fiction, yet it has proven it can do it. I expect that to be a big success in UK and Europe. Surely, in due course a US company would be happy to take that on and bear the expense?
The Covid tech seems to work well too and although approvals are needed, it is only our crappy government that is likely to hold it up. Happy to be corrected if I'm being a little too naive. Thanks for the quality debate from some of you ;)